Company profile
Izotropic Corporation
OTC: IZOZF · Healthcare · Medical - Diagnostics & Research
Canadian filerHQ Surrey, BCReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 29
v0.1 · 5/100 weight · pillars only
↑ disclosure history, market scale · ↓ return on assets, balance-sheet leverage
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$2.3M
Employees
5
as of 2026-08-22
Market cap
$11.7M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$2.3M-3.1M CAD2025
Operating income-$1.5M-2.1M CAD2025
Total assets$300.3k414.7k CAD2025
Liabilities$3.8M5.3M CAD2025
Equity-$3.5M-4.9M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Izotropic Corporation’s revenue?
Izotropic Corporation booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Satellos Bioscience Inc.——Captiva Verde Wellness Corp.——Kiora Pharmaceuticals, Inc.52DUnited Health Products, Inc.26DQuoin Pharmaceuticals, Ltd.37DHemostemix Inc——Key facts
CEORobert Louis Thast
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersSurrey, BC
ExchangeOTC: IZOZF
Employees5
IPO date2021-01-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.